Holen Sie sich die Stockscreener-App
34.22
0.98%
-0.34
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TGTX?
Forum
Prognose
Aktiensplit
Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten
TGTX Advances with Phase 3 Trial Completion for Briumvi Treatment - GuruFocus
TG Therapeutics completes enrollment in subcutaneous BRIUMVI trial By Investing.com - Investing.com India
TG Therapeutics Announces Completion of Enrollment for the Phase 3 Trial Evaluating Subcutaneous BRIUMVI - Yahoo! Finance Canada
Update Report: Should you avoid TG Therapeutics Inc stock right now2026 Fed Impact & Weekly Return Optimization Plans - baoquankhu1.vn
Price-Driven Insight from (TGTX) for Rule-Based Strategy - Stock Traders Daily
TG Therapeutics Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
TG Therapeutics (TGTX) reports financial results for Q4 and full year 2025 - MSN
Fed Watch: Does TG Therapeutics Inc stock benefit from AI growth2026 Trade Ideas & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Gains Recap: Is TG Therapeutics Inc a turnaround storyQuarterly Market Summary & Safe Capital Investment Plans - baoquankhu1.vn
TG Therapeutics, Inc. (TGTX) Stock Forecasts - Yahoo! Finance Canada
BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Maintains Target Price $15 - Moomoo
Fed Meeting: Can TG Therapeutics Inc expand into new marketsMarket Trend Report & Daily Momentum Trading Reports - baoquankhu1.vn
Gains Recap: Is TG Therapeutics Inc undervalued by DCF analysis - baoquankhu1.vn
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
TGTX PE Ratio & Valuation, Is TGTX Overvalued - Intellectia AI
TG Therapeutics Inc (NASDAQ:TGTX): An Affordable Growth Stock with Strong Momentum - ChartMill
TG Therapeutics, Inc. (TGTX) Stock forecasts - Yahoo Finance UK
TG THERAPEUTICS INC (1TGTX.MI) Balance Sheet - Yahoo! Finance Canada
TG Therapeutics, Inc. (TGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
TG Therapeutics Inc. (TGTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
TGTX Stock Price, Quote & Chart | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill
(TGTX) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
TG Therapeutics: Briumvi Performance Aiding Upside, Buybacks Limiting Downside (TGTX) - Seeking Alpha
Analyst Calls: Is TG Therapeutics Inc undervalued by DCF analysis2026 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn
TG Therapeutics, Inc. $TGTX Shares Bought by JPMorgan Chase & Co. - MarketBeat
TG Therapeutics stock price forecast: overbought readings persist as TGTX consolidates below SMA-200 - Traders Union
Nordea Investment Management AB Buys Shares of 79,696 TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. $TGTX Shares Purchased by Assenagon Asset Management S.A. - MarketBeat
Vanguard disaggregates holdings after realignment — TG Therapeutics (TGTX) - Stock Titan
TG Therapeutics announces $100M share buyback program - MSN
US$750 Million Credit Facility Could Be A Game Changer For TG Therapeutics (TGTX) - simplywall.st
A Look At TG Therapeutics (TGTX) Valuation After New US$750 Million Credit Facility - Yahoo Finance
1,922,410 Shares in TG Therapeutics, Inc. $TGTX Acquired by Congress Asset Management Co. - marketbeat.com
Day Trade: Is TG Therapeutics Inc still a buy after recent gains2026 Review & Stepwise Trade Execution Plans - baoquankhu1.vn
CapEx per share of TG Therapeutics, Inc. – MIL:1TGTX - TradingView
TG Therapeutics Credit Deal And Valuation Gap Catch Investor Attention - simplywall.st
TG Therapeutics Files Procedural 8-K on Financial Obligation - The Globe and Mail
(TGTX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
TG Therapeutics, Inc. (TGTX) Enters $750 Million Term Loan Agreement – SEC 8-K Filing Summary - Minichart
Form 8K TG Therapeutics Inc For: 20 March By Investing.com - Investing.com Canada
Form 8K TG Therapeutics Inc For: 20 March - Investing.com
TG Therapeutics, Inc. Enters into First Amendment Agreement for $750 Million Term Loan Facility and $250 Million Uncommitted Additional Facility - marketscreener.com
TG Therapeutics (TGTX) secures $750M 2026 Term Loan maturing 2031 - Stock Titan
TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2025 earnings call transcript - MSN
TG Therapeutics (TGTX) Secures $750 Million Credit Facility - GuruFocus
TG Therapeutics secures $750M credit facility with Blue Owl By Investing.com - Investing.com India
TG Therapeutics board expands share repurchase program to $300M - TipRanks
TG Therapeutics secures $750M credit facility with Blue Owl - investing.com
TG Therapeutics (TGTX) Secures $750M Credit Facility, Expands Sh - GuruFocus
TG Therapeutics Receives $500 Million in New Capital From Blue Owl, Increases Share Buyback - marketscreener.com
TG Therapeutics secures an additional $500 million in non-dilutive capital from Blue Owl and expands share repurchase program to $300 million - marketscreener.com
TG Therapeutics Secures An Additional $500 Million In Non-Dilutive Capital From Blue Owl And Expands Share Repurchase Program To $300 Million - TradingView
TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital from Blue Owl and Expands Share Repurchase Program to $300 Million - The Manila Times
TG Therapeutics Secures an Additional $500 Million in - GlobeNewswire
TG Therapeutics Secures an Additional $500 Million in Non-Dilutive Capital From Blue Owl and Expands Share Repurchase Program to $300 Million - 富途牛牛
1.60%
1.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):